Canon Medical Systems announced the kickoff of new clinical research involving its photon-counting CT (PCCT) technology.
The announcement is a follow-up to an initial agreement with Hiroshima University announced in November. Led by Prof. Kazuo Awai of the Hiroshima University Department of Diagnostic Radiology, the research will explore the clinical usefulness of data captured by PCCT, evaluate and optimize various kinds of diagnostic information provided by PCCT, and determine imaging protocols in order to maximize the functionality of PCCT from a basic level to clinical applications, according to the vendor.
Canon said it will be highlighting its PCCT technology at the International Technical Exhibition of Medical Imaging 2024 (ITEM2024) to be held in Yokohama, Japan, April 12-14, and the 83rd Congress of the Japan Radiological Society and 80th Congress of the Japanese Society of Radiological Technology April 11-14.
![Images show the pectoralis muscles of a healthy male individual who never smoked (age, 66 years; height, 178 cm; body mass index [BMI, calculated as weight in kilograms divided by height in meters squared], 28.4; number of cigarette pack-years, 0; forced expiratory volume in 1 second [FEV1], 97.6% predicted; FEV1: forced vital capacity [FVC] ratio, 0.71; pectoralis muscle area [PMA], 59.4 cm2; pectoralis muscle volume [PMV], 764 cm3) and a male individual with a smoking history and chronic obstructive pulmonary disorder (COPD) (age, 66 years; height, 178 cm; BMI, 27.5; number of cigarette pack-years, 43.2, FEV1, 48% predicted; FEV1:FVC, 0.56; PMA, 35 cm2; PMV, 480.8 cm3) from the Canadian Cohort Obstructive Lung Disease (i.e., CanCOLD) study. The CT image is shown in the axial plane. The PMV is automatically extracted using the developed deep learning model and overlayed onto the lungs for visual clarity.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/03/genkin.25LqljVF0y.jpg?auto=format%2Ccompress&crop=focalpoint&dpr=2&fit=crop&h=167&q=70&w=250)
